Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Carlyle Group Inc. stock logo
CG
The Carlyle Group
$45.62
+8.5%
$40.34
$33.02
$57.50
$16.46B1.852.60 million shs3.51 million shs
Dundee Precious Metals Inc. stock logo
DPM
Dundee Precious Metals
C$18.90
-8.2%
C$18.55
C$10.39
C$20.60
C$2.33B1.2604,523 shs562,048 shs
K92 Mining Inc. (KNT.V) stock logo
KNT
K92 Mining Inc. (KNT.V)
C$7.99
C$7.99
C$1.55
C$8.50
C$1.63BN/A1.13 million shs337,797 shs
10x Genomics, Inc. stock logo
TXG
10x Genomics
$9.49
+8.2%
$8.92
$6.78
$28.25
$1.16B1.942.33 million shs4.04 million shs
10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Carlyle Group Inc. stock logo
CG
The Carlyle Group
+8.52%+12.64%+25.92%-7.99%+7.34%
Dundee Precious Metals Inc. stock logo
DPM
Dundee Precious Metals
-8.21%+3.39%-0.11%+19.47%+72.13%
K92 Mining Inc. (KNT.V) stock logo
KNT
K92 Mining Inc. (KNT.V)
0.00%0.00%0.00%0.00%0.00%
10x Genomics, Inc. stock logo
TXG
10x Genomics
+6.99%+10.22%+18.48%-19.71%-63.49%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
The Carlyle Group Inc. stock logo
CG
The Carlyle Group
4.903 of 5 stars
3.15.02.52.63.52.52.5
Dundee Precious Metals Inc. stock logo
DPM
Dundee Precious Metals
2.9223 of 5 stars
1.80.01.70.03.03.32.5
K92 Mining Inc. (KNT.V) stock logo
KNT
K92 Mining Inc. (KNT.V)
N/AN/AN/AN/AN/AN/AN/AN/A
10x Genomics, Inc. stock logo
TXG
10x Genomics
4.5568 of 5 stars
4.22.00.04.82.13.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
The Carlyle Group Inc. stock logo
CG
The Carlyle Group
2.27
Hold$51.0711.94% Upside
Dundee Precious Metals Inc. stock logo
DPM
Dundee Precious Metals
3.50
Strong BuyC$19.724.33% Upside
K92 Mining Inc. (KNT.V) stock logo
KNT
K92 Mining Inc. (KNT.V)
2.67
Moderate BuyC$13.9774.87% Upside
10x Genomics, Inc. stock logo
TXG
10x Genomics
2.38
Hold$17.8187.65% Upside

Current Analyst Ratings Breakdown

Latest CG, KNT, DPM, and TXG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/12/2025
The Carlyle Group Inc. stock logo
CG
The Carlyle Group
Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetMarket Perform ➝ Market Perform$43.00 ➝ $45.00
5/12/2025
10x Genomics, Inc. stock logo
TXG
10x Genomics
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSell ➝ Sell$7.50 ➝ $6.50
5/12/2025
10x Genomics, Inc. stock logo
TXG
10x Genomics
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$18.00 ➝ $15.00
5/10/2025
10x Genomics, Inc. stock logo
TXG
10x Genomics
Weiss Ratings
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSell (E+) ➝ Sell (E+)
5/9/2025
The Carlyle Group Inc. stock logo
CG
The Carlyle Group
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$43.00 ➝ $49.00
5/9/2025
10x Genomics, Inc. stock logo
TXG
10x Genomics
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$12.00 ➝ $9.00
4/24/2025
10x Genomics, Inc. stock logo
TXG
10x Genomics
Weiss Ratings
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSell (E+) ➝ Sell (E+)
4/21/2025
Dundee Precious Metals Inc. stock logo
DPM
Dundee Precious Metals
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetC$19.50 ➝ C$23.75
4/21/2025
K92 Mining Inc. (KNT.V) stock logo
KNT
K92 Mining Inc. (KNT.V)
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetC$17.50 ➝ C$19.00
4/17/2025
Dundee Precious Metals Inc. stock logo
DPM
Dundee Precious Metals
CIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetC$18.00 ➝ C$21.00
4/14/2025
The Carlyle Group Inc. stock logo
CG
The Carlyle Group
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$57.00 ➝ $44.00
(Data available from 5/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
The Carlyle Group Inc. stock logo
CG
The Carlyle Group
$3.40B4.84$3.93 per share11.62$17.75 per share2.57
Dundee Precious Metals Inc. stock logo
DPM
Dundee Precious Metals
C$337.68M6.91C$6.79 per share2.79C$6.84 per share2.76
K92 Mining Inc. (KNT.V) stock logo
KNT
K92 Mining Inc. (KNT.V)
C$144.51M11.29C$0.19 per share42.50C$0.75 per share10.65
10x Genomics, Inc. stock logo
TXG
10x Genomics
$624.66M1.86N/AN/A$5.81 per share1.63
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
The Carlyle Group Inc. stock logo
CG
The Carlyle Group
$1.02B$2.9516.419.620.9818.81%24.02%6.53%N/A
Dundee Precious Metals Inc. stock logo
DPM
Dundee Precious Metals
C$139.24MC$1.5911.910.0441.23%17.15%9.22%N/A
K92 Mining Inc. (KNT.V) stock logo
KNT
K92 Mining Inc. (KNT.V)
N/AC$0.2532.48N/AN/AN/AN/AN/A
10x Genomics, Inc. stock logo
TXG
10x Genomics
-$182.63M-$1.30N/AN/AN/A-29.90%-25.40%-19.69%N/A

Latest CG, KNT, DPM, and TXG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2025Q1 2025
The Carlyle Group Inc. stock logo
CG
The Carlyle Group
$0.97$1.14+$0.17$0.35$972.27 million$973.10 million
2/12/2025Q4 2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
-$0.32-$0.40-$0.08-$0.40N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
The Carlyle Group Inc. stock logo
CG
The Carlyle Group
$1.403.07%+11.87%47.46%4 Years
Dundee Precious Metals Inc. stock logo
DPM
Dundee Precious Metals
C$0.221.16%N/A13.86%N/A
K92 Mining Inc. (KNT.V) stock logo
KNT
K92 Mining Inc. (KNT.V)
N/AN/AN/AN/AN/A
10x Genomics, Inc. stock logo
TXG
10x Genomics
N/AN/AN/AN/AN/A

Latest CG, KNT, DPM, and TXG Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/23/2025
The Carlyle Group Inc. stock logo
CG
The Carlyle Group
quarterly$0.353.3%5/19/20255/19/20255/27/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
The Carlyle Group Inc. stock logo
CG
The Carlyle Group
1.42
2.32
2.32
Dundee Precious Metals Inc. stock logo
DPM
Dundee Precious Metals
N/A
5.51
6.61
K92 Mining Inc. (KNT.V) stock logo
KNT
K92 Mining Inc. (KNT.V)
4.93
3.25
2.43
10x Genomics, Inc. stock logo
TXG
10x Genomics
N/A
4.97
4.26

Institutional Ownership

CompanyInstitutional Ownership
The Carlyle Group Inc. stock logo
CG
The Carlyle Group
55.88%
Dundee Precious Metals Inc. stock logo
DPM
Dundee Precious Metals
67.42%
K92 Mining Inc. (KNT.V) stock logo
KNT
K92 Mining Inc. (KNT.V)
N/A
10x Genomics, Inc. stock logo
TXG
10x Genomics
84.68%

Insider Ownership

CompanyInsider Ownership
The Carlyle Group Inc. stock logo
CG
The Carlyle Group
27.20%
Dundee Precious Metals Inc. stock logo
DPM
Dundee Precious Metals
0.16%
K92 Mining Inc. (KNT.V) stock logo
KNT
K92 Mining Inc. (KNT.V)
N/A
10x Genomics, Inc. stock logo
TXG
10x Genomics
9.39%
CompanyEmployeesShares OutstandingFree FloatOptionable
The Carlyle Group Inc. stock logo
CG
The Carlyle Group
2,100360.88 million260.39 millionOptionable
Dundee Precious Metals Inc. stock logo
DPM
Dundee Precious Metals
147,000123.49 millionN/ANot Optionable
K92 Mining Inc. (KNT.V) stock logo
KNT
K92 Mining Inc. (KNT.V)
N/A204.20 millionN/ANot Optionable
10x Genomics, Inc. stock logo
TXG
10x Genomics
1,240122.30 million108.91 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

The Carlyle Group stock logo

The Carlyle Group NASDAQ:CG

$45.62 +3.58 (+8.52%)
Closing price 05/12/2025 04:00 PM Eastern
Extended Trading
$45.86 +0.24 (+0.53%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The Carlyle Group Inc. is an investment firm specializing in direct and fund of fund investments. Within direct investments, it specializes in management-led/ Leveraged buyouts, privatizations, divestitures, strategic minority equity investments, structured credit, global distressed and corporate opportunities, small and middle market, equity private placements, consolidations and buildups, senior debt, mezzanine and leveraged finance, and venture and growth capital financings, seed/startup, early venture, emerging growth, turnaround, mid venture, late venture, PIPES. The firm invests across four segments which include Corporate Private Equity, Real Assets, Global Market Strategies, and Solutions. The firm typically invests in industrial, agribusiness, ecological sector, fintech, airports, parking, Plastics, Rubber, diversified natural resources, minerals, farming, aerospace, defense, automotive, consumer, retail, industrial, infrastructure, energy, power, healthcare, software, software enabled services, semiconductors, communications infrastructure, financial technology, utilities, gaming, systems and related supply chain, electronic systems, systems, oil and gas, processing facilities, power generation assets, technology, systems, real estate, financial services, transportation, business services, telecommunications, media, and logistics sectors. Within the industrial sector, the firm invests in manufacturing, building products, packaging, chemicals, metals and mining, forestry and paper products, and industrial consumables and services. In consumer and retail sectors, it invests in food and beverage, retail, restaurants, consumer products, domestic consumption, consumer services, personal care products, direct marketing, and education. Within aerospace, defense, business services, and government services sectors, it seeks to invest in defense electronics, manufacturing and services, government contracting and services, information technology, distribution companies. In telecommunication and media sectors, it invests in cable TV, directories, publishing, entertainment and content delivery services, wireless infrastructure/services, fixed line networks, satellite services, broadband and Internet, and infrastructure. Within real estate, the firm invests in office, hotel, industrial, retail, for sale residential, student housing, hospitality, multifamily residential, homebuilding and building products, and senior living sectors. The firm seeks to make investments in growing business including those with overleveraged balance sheets. The firm seeks to hold its investments for four to six years. In the healthcare sector, it invests in healthcare services, outsourcing services, companies running clinical trials for pharmaceutical companies, managed care, pharmaceuticals, pharmaceutical related services, healthcare IT, medical, products, and devices. It seeks to invest in companies based in Sub-Saharan focusing on Ghana, Kenya, Mozambique, Botswana, Nigeria, Uganda, West Africa, North Africa and South Africa focusing on Tanzania and Zambia; Asia focusing on Pakistan, India, South East Asia, Indonesia, Philippines, Vietnam, Korea, and Japan; Australia; New Zealand; Europe focusing on France, Italy, Denmark, United Kingdom, Germany, Austria, Belgium, Finland, Iceland, Ireland, Netherlands, Norway, Portugal, Spain, Benelux , Sweden, Switzerland, Hungary, Poland, and Russia; Middle East focusing on Bahrain, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, Turkey, and UAE; North America focusing on United States which further invest in Southeastern United States, Texas, Boston, San Francisco Bay Area and Pacific Northwest; Asia Pacific; Soviet Union, Central-Eastern Europe, and Israel; Nordic region; and South America focusing on Mexico, Argentina, Brazil, Chile, and Peru. The firm seeks to invest in food, financial, and healthcare industries in Western China. In the real estate sector, the firm seeks to invest in various locations across Europe focusing on France and Central Europe, United States, Asia focusing on China, and Latin America. It typically invests between $1 million and $50 million for venture investments and between $50 million and $2 billion for buyouts in companies with enterprise value of between $31.57 million and $1000 million and sales value of $10 million and $500 million. It seeks to invest in companies with market capitalization greater than $50 million and EBITDA between $5 million to $25 million. It prefers to take a majority or a minority stake. While investing in Japan, it does not invest in companies with more than 1,000 employees and prefers companies' worth between $100 million and $150 million. The firm originates, structures, and acts as lead equity investor in the transactions. The Carlyle Group Inc. was founded in 1987 and is based in Washington, District of Columbia with additional offices in 21 countries across 5 continents (North America, South America, Asia, Australia and Europe).

Dundee Precious Metals stock logo

Dundee Precious Metals TSE:DPM

C$18.90 -1.69 (-8.21%)
As of 05/12/2025 04:16 PM Eastern

Dundee Precious Metals Inc., a gold mining company, engages in the acquisition, exploration, development, mining, and processing of precious metals. The company primarily explores for gold, copper, and silver deposits. It holds a portfolio of projects located in Bulgaria, Namibia, Serbia, and Ecuador. The company is based in Toronto, Canada.

K92 Mining Inc. (KNT.V) stock logo

K92 Mining Inc. (KNT.V) CVE:KNT

C$7.99 0.00 (0.00%)
As of 12/8/2020

K92 Mining Inc. engages in the mining, exploration, and development of mineral deposits in Papua New Guinea. The company produces gold, copper, and silver. Its principal property is the Kainantu property that covers an area of 725 square kilometers located in the Eastern Highlands province. The company is headquartered in Vancouver, Canada.

10x Genomics stock logo

10x Genomics NASDAQ:TXG

$9.49 +0.72 (+8.21%)
Closing price 05/12/2025 04:00 PM Eastern
Extended Trading
$9.60 +0.11 (+1.16%)
As of 05/12/2025 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.